<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-06-01" modified="2017-12-20" version="200">
<accession>O14920</accession>
<accession>B4DZ30</accession>
<accession>B4E0U4</accession>
<accession>O75327</accession>
<name>IKKB_HUMAN</name>
<protein>
<recommendedName>
<fullName>Inhibitor of nuclear factor kappa-B kinase subunit beta</fullName>
<shortName>I-kappa-B-kinase beta</shortName>
<shortName>IKK-B</shortName>
<shortName>IKK-beta</shortName>
<shortName>IkBKB</shortName>
<ecNumber>2.7.11.10</ecNumber>
</recommendedName>
<alternativeName>
<fullName>I-kappa-B kinase 2</fullName>
<shortName>IKK2</shortName>
</alternativeName>
<alternativeName>
<fullName>Nuclear factor NF-kappa-B inhibitor kinase beta</fullName>
<shortName>NFKBIKB</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">IKBKB</name>
<name type="synonym">IKKB</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Science" volume="278" first="860" last="866">
<title>IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.</title>
<authorList>
<person name="Mercurio F."/>
<person name="Zhu H."/>
<person name="Murray B.W."/>
<person name="Shevchenko A."/>
<person name="Bennett B.L."/>
<person name="Li J.W."/>
<person name="Young D.B."/>
<person name="Barbosa M."/>
<person name="Mann M."/>
<person name="Manning A."/>
<person name="Rao A."/>
</authorList>
<dbReference type="PubMed" id="9346484"/>
<dbReference type="DOI" id="10.1126/science.278.5339.860"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF LYS-44; SER-177 AND SER-181</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Science" volume="278" first="866" last="869">
<title>IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.</title>
<authorList>
<person name="Woronicz J.D."/>
<person name="Gao X."/>
<person name="Cao Z."/>
<person name="Rothe M."/>
<person name="Goeddel D.V."/>
</authorList>
<dbReference type="PubMed" id="9346485"/>
<dbReference type="DOI" id="10.1126/science.278.5339.866"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF LYS-44</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Gene" volume="222" first="31" last="40">
<title>IkappaB kinase-alpha and -beta genes are coexpressed in adult and embryonic tissues but localized to different human chromosomes.</title>
<authorList>
<person name="Hu M.C.-T."/>
<person name="Wang Y.-P."/>
</authorList>
<dbReference type="PubMed" id="9813230"/>
<dbReference type="DOI" id="10.1016/S0378-1119(98)00462-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Heart</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1998" name="Cytogenet. Cell Genet." volume="82" first="32" last="33">
<title>Assignment of IkappaB kinase beta (IKBKB) to human chromosome band 8p12-->p11 by in situ hybridization.</title>
<authorList>
<person name="Shindo M."/>
<person name="Nakano H."/>
<person name="Sakon S."/>
<person name="Yagita H."/>
<person name="Mihara M."/>
<person name="Okumura K."/>
</authorList>
<dbReference type="PubMed" id="9763654"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>GENE MAPPING</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4)</scope>
<source>
<tissue>Testis</tissue>
<tissue>Thymus</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT TRP-554</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="18574" last="18579">
<title>Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling.</title>
<authorList>
<person name="Mittal R."/>
<person name="Peak-Chew S.Y."/>
<person name="McMahon H.T."/>
</authorList>
<dbReference type="PubMed" id="17116858"/>
<dbReference type="DOI" id="10.1073/pnas.0608995103"/>
</citation>
<scope>PROTEIN SEQUENCE OF 170-182 (ISOFORM 1)</scope>
<scope>INACTIVATION BY YERSINIA YOPJ (MICROBIAL INFECTION)</scope>
<scope>ACETYLATION AT THR-180 (MICROBIAL INFECTION)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="7336" last="7343">
<title>Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase.</title>
<authorList>
<person name="Nemoto S."/>
<person name="DiDonato J.A."/>
<person name="Lin A."/>
</authorList>
<dbReference type="PubMed" id="9819420"/>
<dbReference type="DOI" id="10.1128/MCB.18.12.7336"/>
</citation>
<scope>IKK PHOSPHORYLATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="Nature" volume="395" first="292" last="296">
<title>IKAP is a scaffold protein of the IkappaB kinase complex.</title>
<authorList>
<person name="Cohen L."/>
<person name="Henzel W.J."/>
<person name="Baeuerle P.A."/>
</authorList>
<dbReference type="PubMed" id="9751059"/>
<dbReference type="DOI" id="10.1038/26254"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH CHUK; NFKBIA; RELA; ELP1 AND MAP3K14</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="3044" last="3053">
<title>The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation.</title>
<authorList>
<person name="Sanz L."/>
<person name="Sanchez P."/>
<person name="Lallena M.-J."/>
<person name="Diaz-Meco M.T."/>
<person name="Moscat J."/>
</authorList>
<dbReference type="PubMed" id="10356400"/>
<dbReference type="DOI" id="10.1093/emboj/18.11.3044"/>
</citation>
<scope>INTERACTION WITH SQSTM1; PRKCZ AND PRKCI</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="2180" last="2188">
<title>Activation of IkappaB kinase beta by protein kinase C isoforms.</title>
<authorList>
<person name="Lallena M.J."/>
<person name="Diaz-Meco M.T."/>
<person name="Bren G."/>
<person name="Paya C.V."/>
<person name="Moscat J."/>
</authorList>
<dbReference type="PubMed" id="10022904"/>
<dbReference type="DOI" id="10.1128/MCB.19.3.2180"/>
</citation>
<scope>PHOSPHORYLATION AT SER-177 AND SER-181</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Science" volume="284" first="309" last="313">
<title>Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation.</title>
<authorList>
<person name="Delhase M."/>
<person name="Hayakawa M."/>
<person name="Chen Y."/>
<person name="Karin M."/>
</authorList>
<dbReference type="PubMed" id="10195894"/>
<dbReference type="DOI" id="10.1126/science.284.5412.309"/>
</citation>
<scope>PHOSPHORYLATION AT SER-177; SER-181; SER-670; SER-672; SER-675; SER-682; SER-689; SER-692; SER-695; SER-697; SER-705; SER-733; SER-740 AND SER-750</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="4532" last="4542">
<title>PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex.</title>
<authorList>
<person name="Bonnet M.C."/>
<person name="Weil R."/>
<person name="Dam E."/>
<person name="Hovanessian A.G."/>
<person name="Meurs E.F."/>
</authorList>
<dbReference type="PubMed" id="10848580"/>
<dbReference type="DOI" id="10.1128/MCB.20.13.4532-4542.2000"/>
</citation>
<scope>INTERACTION WITH EIF2AK2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2000" name="Nature" volume="404" first="778" last="782">
<title>NAK is an IkappaB kinase-activating kinase.</title>
<authorList>
<person name="Tojima Y."/>
<person name="Fujimoto A."/>
<person name="Delhase M."/>
<person name="Chen Y."/>
<person name="Hatakeyama S."/>
<person name="Nakayama K."/>
<person name="Kaneko Y."/>
<person name="Nimura Y."/>
<person name="Motoyama N."/>
<person name="Ikeda K."/>
<person name="Karin M."/>
<person name="Nakanishi M."/>
</authorList>
<dbReference type="PubMed" id="10783893"/>
<dbReference type="DOI" id="10.1038/35008109"/>
</citation>
<scope>PHOSPHORYLATION AT SER-177 AND SER-181 BY TBK1</scope>
<scope>MUTAGENESIS OF 177-SER--SER-181</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="22215" last="22222">
<title>Direct phosphorylation of NF-kappa B1 p105 by the Ikappa B kinase complex on serine 927 is essential for signal-induced p105 proteolysis.</title>
<authorList>
<person name="Salmeron A."/>
<person name="Janzen J."/>
<person name="Soneji Y."/>
<person name="Bump N."/>
<person name="Kamens J."/>
<person name="Allen H."/>
<person name="Ley S.C."/>
</authorList>
<dbReference type="PubMed" id="11297557"/>
<dbReference type="DOI" id="10.1074/jbc.M101754200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF NFKB1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="37029" last="37036">
<title>Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases.</title>
<authorList>
<person name="Chariot A."/>
<person name="Leonardi A."/>
<person name="Muller J."/>
<person name="Bonif M."/>
<person name="Brown K."/>
<person name="Siebenlist U."/>
</authorList>
<dbReference type="PubMed" id="12133833"/>
<dbReference type="DOI" id="10.1074/jbc.M205069200"/>
</citation>
<scope>INTERACTION WITH IKBKG AND TANK</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="3549" last="3561">
<title>Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase.</title>
<authorList>
<person name="Wu R.-C."/>
<person name="Qin J."/>
<person name="Hashimoto Y."/>
<person name="Wong J."/>
<person name="Xu J."/>
<person name="Tsai S.Y."/>
<person name="Tsai M.-J."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="11971985"/>
<dbReference type="DOI" id="10.1128/MCB.22.10.3549-3561.2002"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH CREBBP; NCOA2; NCOA3; IKKA AND IKBKG</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="2029" last="2041">
<title>Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation.</title>
<authorList>
<person name="Tegethoff S."/>
<person name="Behlke J."/>
<person name="Scheidereit C."/>
</authorList>
<dbReference type="PubMed" id="12612076"/>
<dbReference type="DOI" id="10.1128/MCB.23.6.2029-2041.2003"/>
</citation>
<scope>COMPOSITION OF THE IKK COMPLEX</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="Cell" volume="117" first="225" last="237">
<title>IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.</title>
<authorList>
<person name="Hu M.C."/>
<person name="Lee D.F."/>
<person name="Xia W."/>
<person name="Golfman L.S."/>
<person name="Ou-Yang F."/>
<person name="Yang J.Y."/>
<person name="Zou Y."/>
<person name="Bao S."/>
<person name="Hanada N."/>
<person name="Saso H."/>
<person name="Kobayashi R."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="15084260"/>
<dbReference type="DOI" id="10.1016/S0092-8674(04)00302-2"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FOXO3</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="15652" last="15661">
<title>Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.</title>
<authorList>
<person name="Han K.J."/>
<person name="Su X."/>
<person name="Xu L.-G."/>
<person name="Bin L.H."/>
<person name="Zhang J."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="14739303"/>
<dbReference type="DOI" id="10.1074/jbc.M311629200"/>
</citation>
<scope>INTERACTION WITH TICAM1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="51897" last="51907">
<title>PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kappaB and caspase-1 activation in macrophages.</title>
<authorList>
<person name="Bruey J.-M."/>
<person name="Bruey-Sedano N."/>
<person name="Newman R."/>
<person name="Chandler S."/>
<person name="Stehlik C."/>
<person name="Reed J.C."/>
</authorList>
<dbReference type="PubMed" id="15456791"/>
<dbReference type="DOI" id="10.1074/jbc.M406741200"/>
</citation>
<scope>INTERACTION WITH NALP2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="8603" last="8607">
<title>beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha.</title>
<authorList>
<person name="Witherow D.S."/>
<person name="Garrison T.R."/>
<person name="Miller W.E."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="15173580"/>
<dbReference type="DOI" id="10.1073/pnas.0402851101"/>
</citation>
<scope>INTERACTION WITH ARRB1 AND ARRB2</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="8945" last="8950">
<title>Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation.</title>
<authorList>
<person name="Reynaert N.L."/>
<person name="Ckless K."/>
<person name="Korn S.H."/>
<person name="Vos N."/>
<person name="Guala A.S."/>
<person name="Wouters E.F."/>
<person name="van der Vliet A."/>
<person name="Janssen-Heininger Y.M."/>
</authorList>
<dbReference type="PubMed" id="15184672"/>
<dbReference type="DOI" id="10.1073/pnas.0400588101"/>
</citation>
<scope>S-NITROSYLATION AT CYS-179</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="29233" last="29241">
<title>NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation.</title>
<authorList>
<person name="Hu W.-H."/>
<person name="Pendergast J.S."/>
<person name="Mo X.-M."/>
<person name="Brambilla R."/>
<person name="Bracchi-Ricard V."/>
<person name="Li F."/>
<person name="Walters W.M."/>
<person name="Blits B."/>
<person name="He L."/>
<person name="Schaal S.M."/>
<person name="Bethea J.R."/>
</authorList>
<dbReference type="PubMed" id="15951441"/>
<dbReference type="DOI" id="10.1074/jbc.M501670200"/>
</citation>
<scope>INTERACTION WITH NIBP</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="40965" last="40973">
<title>3-Phosphoinositide-dependent protein kinase-1-mediated IkappaB kinase beta (IkkB) phosphorylation activates NF-kappaB signaling.</title>
<authorList>
<person name="Tanaka H."/>
<person name="Fujita N."/>
<person name="Tsuruo T."/>
</authorList>
<dbReference type="PubMed" id="16207722"/>
<dbReference type="DOI" id="10.1074/jbc.M506235200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-181 BY PDPK1</scope>
<scope>INTERACTION WITH PDPK1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="43272" last="43279">
<title>Site-specific monoubiquitination of IkappaB kinase IKKbeta regulates its phosphorylation and persistent activation.</title>
<authorList>
<person name="Carter R.S."/>
<person name="Pennington K.N."/>
<person name="Arrate P."/>
<person name="Oltz E.M."/>
<person name="Ballard D.W."/>
</authorList>
<dbReference type="PubMed" id="16267042"/>
<dbReference type="DOI" id="10.1074/jbc.M508656200"/>
</citation>
<scope>UBIQUITINATION AT LYS-163</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="Nature" volume="437" first="1167" last="1172">
<title>Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.</title>
<authorList>
<person name="Meylan E."/>
<person name="Curran J."/>
<person name="Hofmann K."/>
<person name="Moradpour D."/>
<person name="Binder M."/>
<person name="Bartenschlager R."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="16177806"/>
<dbReference type="DOI" id="10.1038/nature04193"/>
</citation>
<scope>INTERACTION WITH MAVS</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="18154" last="18159">
<title>Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.</title>
<authorList>
<person name="Cummins E.P."/>
<person name="Berra E."/>
<person name="Comerford K.M."/>
<person name="Ginouves A."/>
<person name="Fitzgerald K.T."/>
<person name="Seeballuck F."/>
<person name="Godson C."/>
<person name="Nielsen J.E."/>
<person name="Moynagh P."/>
<person name="Pouyssegur J."/>
<person name="Taylor C.T."/>
</authorList>
<dbReference type="PubMed" id="17114296"/>
<dbReference type="DOI" id="10.1073/pnas.0602235103"/>
</citation>
<scope>HYDROXYLATION AT PRO-191</scope>
<scope>MUTAGENESIS OF PRO-191</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Science" volume="312" first="1211" last="1214">
<title>Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation.</title>
<authorList>
<person name="Mukherjee S."/>
<person name="Keitany G."/>
<person name="Li Y."/>
<person name="Wang Y."/>
<person name="Ball H.L."/>
<person name="Goldsmith E.J."/>
<person name="Orth K."/>
</authorList>
<dbReference type="PubMed" id="16728640"/>
<dbReference type="DOI" id="10.1126/science.1126867"/>
</citation>
<scope>INTERACTION WITH YOPJ (MICROBIAL INFECTION)</scope>
<scope>ACETYLATION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="Science" volume="311" first="1141" last="1146">
<title>Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.</title>
<authorList>
<person name="Wu Z.H."/>
<person name="Shi Y."/>
<person name="Tibbetts R.S."/>
<person name="Miyamoto S."/>
</authorList>
<dbReference type="PubMed" id="16497931"/>
<dbReference type="DOI" id="10.1126/science.1121513"/>
</citation>
<scope>INTERACTION WITH ATM</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="10117" last="10131">
<title>Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1.</title>
<authorList>
<person name="Ohnuma K."/>
<person name="Uchiyama M."/>
<person name="Yamochi T."/>
<person name="Nishibashi K."/>
<person name="Hosono O."/>
<person name="Takahashi N."/>
<person name="Kina S."/>
<person name="Tanaka H."/>
<person name="Lin X."/>
<person name="Dang N.H."/>
<person name="Morimoto C."/>
</authorList>
<dbReference type="PubMed" id="17287217"/>
<dbReference type="DOI" id="10.1074/jbc.M609157200"/>
</citation>
<scope>IDENTIFICATION IN A MEMBRANE RAFT COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="27572" last="27577">
<title>FAF1 suppresses IkappaB kinase (IKK) activation by disrupting the IKK complex assembly.</title>
<authorList>
<person name="Park M.Y."/>
<person name="Moon J.H."/>
<person name="Lee K.S."/>
<person name="Choi H.I."/>
<person name="Chung J."/>
<person name="Hong H.J."/>
<person name="Kim E."/>
</authorList>
<dbReference type="PubMed" id="17684021"/>
<dbReference type="DOI" id="10.1074/jbc.C700106200"/>
</citation>
<scope>INTERACTION WITH FAF1</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="908" last="913">
<title>Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.</title>
<authorList>
<person name="Lobry C."/>
<person name="Lopez T."/>
<person name="Israel A."/>
<person name="Weil R."/>
</authorList>
<dbReference type="PubMed" id="17213322"/>
<dbReference type="DOI" id="10.1073/pnas.0606982104"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF BCL10</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2000" name="Am. J. Physiol." volume="278" first="C451" last="C462">
<title>The I kappa B/NF-kappa B system: a key determinant of mucosal inflammation and protection.</title>
<authorList>
<person name="Jobin C."/>
<person name="Sartor R.B."/>
</authorList>
<dbReference type="PubMed" id="10712233"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2008" name="Immunol. Res." volume="42" first="3" last="18">
<title>The IkappaB kinase complex: master regulator of NF-kappaB signaling.</title>
<authorList>
<person name="Solt L.A."/>
<person name="May M.J."/>
</authorList>
<dbReference type="PubMed" id="18626576"/>
<dbReference type="DOI" id="10.1007/s12026-008-8025-1"/>
</citation>
<scope>REVIEW</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-672</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2009" name="Biochem. Biophys. Res. Commun." volume="389" first="156" last="161">
<title>Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation.</title>
<authorList>
<person name="Kuo H.P."/>
<person name="Lee D.F."/>
<person name="Xia W."/>
<person name="Lai C.C."/>
<person name="Li L.Y."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="19716809"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2009.08.127"/>
</citation>
<scope>INTERACTION WITH NAA10</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF NAA10</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2009" name="Cell. Signal." volume="21" first="95" last="102">
<title>PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha-induced IKKbeta-NF-kappaB activation.</title>
<authorList>
<person name="Sun W."/>
<person name="Yu Y."/>
<person name="Dotti G."/>
<person name="Shen T."/>
<person name="Tan X."/>
<person name="Savoldo B."/>
<person name="Pass A.K."/>
<person name="Chu M."/>
<person name="Zhang D."/>
<person name="Lu X."/>
<person name="Fu S."/>
<person name="Lin X."/>
<person name="Yang J."/>
</authorList>
<dbReference type="PubMed" id="18930133"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2008.09.012"/>
</citation>
<scope>DEPHOSPHORYLATION AT SER-177 AND SER-181</scope>
<scope>INTERACTION WITH PPM1A AND PPM1B</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-672</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="Cell" volume="141" first="483" last="496">
<title>NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.</title>
<authorList>
<person name="Cui J."/>
<person name="Zhu L."/>
<person name="Xia X."/>
<person name="Wang H.Y."/>
<person name="Legras X."/>
<person name="Hong J."/>
<person name="Ji J."/>
<person name="Shen P."/>
<person name="Zheng S."/>
<person name="Chen Z.J."/>
<person name="Wang R.F."/>
</authorList>
<dbReference type="PubMed" id="20434986"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.03.040"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NLRC5</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2009" name="J. Biochem." volume="146" first="821" last="832">
<title>Ro52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signalling.</title>
<authorList>
<person name="Wada K."/>
<person name="Niida M."/>
<person name="Tanaka M."/>
<person name="Kamitani T."/>
</authorList>
<dbReference type="PubMed" id="19675099"/>
<dbReference type="DOI" id="10.1093/jb/mvp127"/>
</citation>
<scope>INTERACTION WITH TRIM21</scope>
<scope>MONOUBIQUITINATION</scope>
<scope>UBIQUITINATION INACTIVATION BY YERSINIA YOPJ (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF LYS-163; SER-177 AND SER-181</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2010" name="J. Virol." volume="84" first="7267" last="7277">
<title>Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta.</title>
<authorList>
<person name="Yoboua F."/>
<person name="Martel A."/>
<person name="Duval A."/>
<person name="Mukawera E."/>
<person name="Grandvaux N."/>
</authorList>
<dbReference type="PubMed" id="20410276"/>
<dbReference type="DOI" id="10.1128/JVI.00142-10"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF RELA</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2010" name="Mol. Cell" volume="39" first="570" last="582">
<title>Nuclear IKKbeta is an adaptor protein for IkappaBalpha ubiquitination and degradation in UV-induced NF-kappaB activation.</title>
<authorList>
<person name="Tsuchiya Y."/>
<person name="Asano T."/>
<person name="Nakayama K."/>
<person name="Kato T. Jr."/>
<person name="Karin M."/>
<person name="Kamata H."/>
</authorList>
<dbReference type="PubMed" id="20797629"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.07.030"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2011" name="Biochem. J." volume="434" first="93" last="104">
<title>Novel cross-talk within the IKK family controls innate immunity.</title>
<authorList>
<person name="Clark K."/>
<person name="Peggie M."/>
<person name="Plater L."/>
<person name="Sorcek R.J."/>
<person name="Young E.R."/>
<person name="Madwed J.B."/>
<person name="Hough J."/>
<person name="McIver E.G."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="21138416"/>
<dbReference type="DOI" id="10.1042/BJ20101701"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION BY TBK1 AND IKBKE</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="42856" last="42866">
<title>The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-kappaB signaling.</title>
<authorList>
<person name="Wang W."/>
<person name="Guo M."/>
<person name="Hu L."/>
<person name="Cai J."/>
<person name="Zeng Y."/>
<person name="Luo J."/>
<person name="Shu Z."/>
<person name="Li W."/>
<person name="Huang Z."/>
</authorList>
<dbReference type="PubMed" id="23091055"/>
<dbReference type="DOI" id="10.1074/jbc.M112.399923"/>
</citation>
<scope>INTERACTION WITH ZNF268</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2013" name="Cell Rep." volume="3" first="724" last="733">
<title>IKKepsilon-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex.</title>
<authorList>
<person name="Zhou A.Y."/>
<person name="Shen R.R."/>
<person name="Kim E."/>
<person name="Lock Y.J."/>
<person name="Xu M."/>
<person name="Chen Z.J."/>
<person name="Hahn W.C."/>
</authorList>
<dbReference type="PubMed" id="23453969"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.01.031"/>
</citation>
<scope>INTERACTION WITH IKBKE</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-672 AND SER-675</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="55">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="14" last="27">
<title>A-kinase-anchoring protein-Lbc anchors IkappaB kinase beta to support interleukin-6-mediated cardiomyocyte hypertrophy.</title>
<authorList>
<person name="del Vescovo C.D."/>
<person name="Cotecchia S."/>
<person name="Diviani D."/>
</authorList>
<dbReference type="PubMed" id="23090968"/>
<dbReference type="DOI" id="10.1128/MCB.00887-12"/>
</citation>
<scope>INTERACTION WITH AKAP13</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2013" name="N. Engl. J. Med." volume="369" first="2504" last="2514">
<title>Deficiency of innate and acquired immunity caused by an IKBKB mutation.</title>
<authorList>
<person name="Pannicke U."/>
<person name="Baumann B."/>
<person name="Fuchs S."/>
<person name="Henneke P."/>
<person name="Rensing-Ehl A."/>
<person name="Rizzi M."/>
<person name="Janda A."/>
<person name="Hese K."/>
<person name="Schlesier M."/>
<person name="Holzmann K."/>
<person name="Borte S."/>
<person name="Laux C."/>
<person name="Rump E.M."/>
<person name="Rosenberg A."/>
<person name="Zelinski T."/>
<person name="Schrezenmeier H."/>
<person name="Wirth T."/>
<person name="Ehl S."/>
<person name="Schroeder M.L."/>
<person name="Schwarz K."/>
</authorList>
<dbReference type="PubMed" id="24369075"/>
<dbReference type="DOI" id="10.1056/NEJMoa1309199"/>
</citation>
<scope>INVOLVEMENT IN IMD15</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-675</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="58">
<citation type="journal article" date="2015" name="Cell. Signal." volume="27" first="2343" last="2354">
<title>IFIT5 positively regulates NF-kappaB signaling through synergizing the recruitment of IkappaB kinase (IKK) to TGF-beta-activated kinase 1 (TAK1).</title>
<authorList>
<person name="Zheng C."/>
<person name="Zheng Z."/>
<person name="Zhang Z."/>
<person name="Meng J."/>
<person name="Liu Y."/>
<person name="Ke X."/>
<person name="Hu Q."/>
<person name="Wang H."/>
</authorList>
<dbReference type="PubMed" id="26334375"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2015.08.018"/>
</citation>
<scope>INTERACTION WITH IFIT5</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2016" name="Exp. Cell Res." volume="347" first="65" last="73">
<title>LRRC14 attenuates Toll-like receptor-mediated NF-kappa-B signaling through disruption of IKK complex.</title>
<authorList>
<person name="Wu C."/>
<person name="Yang Y."/>
<person name="Ou J."/>
<person name="Zhu L."/>
<person name="Zhao W."/>
<person name="Cui J."/>
</authorList>
<dbReference type="PubMed" id="27426725"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2016.07.011"/>
</citation>
<scope>INTERACTION WITH LRRC14</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2008" name="Structure" volume="16" first="798" last="808">
<title>Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site.</title>
<authorList>
<person name="Rushe M."/>
<person name="Silvian L."/>
<person name="Bixler S."/>
<person name="Chen L.L."/>
<person name="Cheung A."/>
<person name="Bowes S."/>
<person name="Cuervo H."/>
<person name="Berkowitz S."/>
<person name="Zheng T."/>
<person name="Guckian K."/>
<person name="Pellegrini M."/>
<person name="Lugovskoy A."/>
</authorList>
<dbReference type="PubMed" id="18462684"/>
<dbReference type="DOI" id="10.1016/j.str.2008.02.012"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 701-742</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] SER-360</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] SER-360; ARG-369; GLN-526; THR-710 AND LEU-734</scope>
</reference>
<comment type="function">
<text evidence="16 21 34 41 42 43 44 45">Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on 2 critical serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. In addition to the NF-kappa-B inhibitors, phosphorylates several other components of the signaling pathway including NEMO/IKBKG, NF-kappa-B subunits RELA and NFKB1, as well as IKK-related kinases TBK1 and IKBKE. IKK-related kinase phosphorylations may prevent the overproduction of inflammatory mediators since they exert a negative regulation on canonical IKKs. Phosphorylates FOXO3, mediating the TNF-dependent inactivation of this pro-apoptotic transcription factor. Also phosphorylates other substrates including NCOA3, BCL10 and IRS1. Within the nucleus, acts as an adapter protein for NFKBIA degradation in UV-induced NF-kappa-B activation.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + [I-kappa-B protein] = ADP + [I-kappa-B phosphoprotein].</text>
</comment>
<comment type="subunit">
<text evidence="7 8 13 15 17 18 19 20 21 22 24 25 26 27 29 35 37 39 40 41 43 46 47 49 50 53">Component of the I-kappa-B-kinase (IKK) core complex consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-beta/IKBKB dimers are associated with four gamma/IKBKG subunits. The IKK core complex seems to associate with regulatory or adapter proteins to form a IKK-signalosome holo-complex (PubMed:12612076). The IKK complex associates with TERF2IP/RAP1, leading to promote IKK-mediated phosphorylation of RELA/p65 (By similarity). Part of a complex composed of NCOA2, NCOA3, CHUK/IKKA, IKBKB, IKBKG and CREBBP (PubMed:11971985). Part of a 70-90 kDa complex at least consisting of CHUK/IKKA, IKBKB, NFKBIA, RELA, ELP1 and MAP3K14 (PubMed:9751059). Found in a membrane raft complex, at least composed of BCL10, CARD11, DPP4 and IKBKB (PubMed:17287217). Interacts with SQSTM1 through PRKCZ or PRKCI (PubMed:10356400). Forms an NGF-induced complex with IKBKB, PRKCI and TRAF6 (By similarity). May interact with MAVS/IPS1 (PubMed:16177806). Interacts with NALP2 (PubMed:15456791). Interacts with TICAM1 (PubMed:14739303). Interacts with FAF1; the interaction disrupts the IKK complex formation (PubMed:17684021). Interacts with ATM (PubMed:16497931). Part of a ternary complex consisting of TANK, IKBKB and IKBKG (PubMed:12133833). Interacts with NIBP; the interaction is direct (PubMed:15951441). Interacts with ARRB1 and ARRB2 (PubMed:15173580). Interacts with TRIM21 (PubMed:19675099). Interacts with NLRC5; prevents IKBKB phosphorylation and kinase activity (PubMed:20434986). Interacts with PDPK1 (PubMed:16207722). Interacts with EIF2AK2/PKR (PubMed:10848580). The phosphorylated form interacts with PPM1A and PPM1B (PubMed:18930133). Interacts with ZNF268 isoform 2; the interaction is further increased in a TNF-alpha-dependent manner (PubMed:23091055). Interacts with IKBKE (PubMed:23453969). Interacts with NAA10, leading to NAA10 degradation (PubMed:19716809). Interacts with FOXO3 (PubMed:15084260). Interacts with AKAP13 (PubMed:23090968). Interacts with IFIT5; the interaction synergizes the recruitment of IKK to MAP3K7 and enhances IKK phosphorylation (PubMed:26334375). Interacts with LRRC14; disrupts IKBKB-IKBKG interaction preventing I-kappa-B-kinase (IKK) core complex formation and leading to a decrease of IKBKB phosphorylation and NF-kappaB activation (PubMed:27426725).</text>
</comment>
<comment type="subunit">
<text evidence="30">(Microbial infection) Interacts with Yersinia yopJ.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-81266"/>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-448680">
<id>O14965</id>
<label>AURKA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-81249">
<id>O15111</id>
<label>CHUK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
<label>IKBKG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>33</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-751001">
<id>Q14145</id>
<label>KEAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-6973030">
<id>P03230</id>
<label>LMP1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-358011">
<id>Q99558</id>
<label>MAP3K14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-81196">
<id>Q9Y6Q9</id>
<label>NCOA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-300010">
<id>P19838</id>
<label>NFKB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-307386">
<id>P25963</id>
<label>NFKBIA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>27</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-712311">
<id>P67775</id>
<label>PPP2CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-351193">
<id>P23396</id>
<label>RPS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-1553984">
<id>Q9UGK3</id>
<label>STAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-5236464">
<id>P03409</id>
<label>tax</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-1051794">
<id>Q9UKE5</id>
<label>TNIK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-1047085">
<id>Q92574</id>
<label>TSC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-4291651">
<id>P24772</id>
<label>VACWR196</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81266"/>
<interactant intactId="EBI-5326026">
<id>Q5D1E7</id>
<label>Zc3h12a</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="44">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="44">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="35">Membrane raft</location>
</subcellularLocation>
<text evidence="35">Colocalized with DPP4 in membrane rafts.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O14920-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O14920-2</id>
<name>2</name>
<sequence type="described" ref="VSP_041825"/>
</isoform>
<isoform>
<id>O14920-3</id>
<name>3</name>
<sequence type="described" ref="VSP_041826 VSP_041827"/>
</isoform>
<isoform>
<id>O14920-4</id>
<name>4</name>
<sequence type="described" ref="VSP_043408"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Highly expressed in heart, placenta, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis and peripheral blood.</text>
</comment>
<comment type="domain">
<text evidence="38">The kinase domain is located in the N-terminal region. The leucine zipper is important to allow homo- and hetero-dimerization. At the C-terminal region is located the region responsible for the interaction with NEMO/IKBKG.</text>
</comment>
<comment type="PTM">
<text evidence="11 12 14 27">Upon cytokine stimulation, phosphorylated on Ser-177 and Ser-181 by MEKK1 and/or MAP3K14/NIK as well as TBK1 and PRKCZ; which enhances activity. Once activated, autophosphorylates on the C-terminal serine cluster; which decreases activity and prevents prolonged activation of the inflammatory response. Phosphorylated by the IKK-related kinases TBK1 and IKBKE, which is associated with reduced CHUK/IKKA and IKBKB activity and NF-kappa-B-dependent gene transcription. Dephosphorylated at Ser-177 and Ser-181 by PPM1A and PPM1B.</text>
</comment>
<comment type="PTM">
<text evidence="30 33">(Microbial infection) Acetylation of Thr-180 by Yersinia yopJ prevents phosphorylation and activation, thus blocking the I-kappa-B pathway.</text>
</comment>
<comment type="PTM">
<text evidence="28 40">Ubiquitinated. Monoubiquitination involves TRIM21 that leads to inhibition of Tax-induced NF-kappa-B signaling. According to PubMed:19675099, 'Ser-163' does not serve as a monoubiquitination site. According to PubMed:16267042, ubiquitination on 'Ser-163' modulates phosphorylation on C-terminal serine residues.</text>
</comment>
<comment type="PTM">
<text evidence="40">(Microbial infection) Monoubiquitination by TRIM21 is disrupted by Yersinia yopJ.</text>
</comment>
<comment type="PTM">
<text evidence="32">Hydroxylated by PHD1/EGLN2, loss of hydroxylation under hypoxic conditions results in activation of NF-kappa-B.</text>
</comment>
<comment type="disease" evidence="48">
<disease id="DI-04000">
<name>Immunodeficiency 15</name>
<acronym>IMD15</acronym>
<description>An autosomal recessive primary immunodeficiency disorder characterized by onset in infancy of life-threatening bacterial, fungal, and viral infections and failure to thrive. Laboratory studies show hypo- or agammaglobulinemia with relatively normal numbers of B and T-cells, and impaired differentiation and activation of immune cells.</description>
<dbReference type="MIM" id="615592"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="9">Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. I-kappa-B kinase subfamily.</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/ikbkb/"/>
</comment>
<dbReference type="EC" id="2.7.11.10"/>
<dbReference type="EMBL" id="AF029684">
<property type="protein sequence ID" value="AAC51860.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF080158">
<property type="protein sequence ID" value="AAD08997.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF031416">
<property type="protein sequence ID" value="AAC64675.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK302723">
<property type="protein sequence ID" value="BAG63942.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK303528">
<property type="protein sequence ID" value="BAG64556.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK316418">
<property type="protein sequence ID" value="BAH14789.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY663108">
<property type="protein sequence ID" value="AAT65965.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC083973">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC006231">
<property type="protein sequence ID" value="AAH06231.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55228.1">
<molecule id="O14920-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56535.1">
<molecule id="O14920-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6128.1">
<molecule id="O14920-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001177649.1">
<molecule id="O14920-2"/>
<property type="nucleotide sequence ID" value="NM_001190720.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001229707.1">
<molecule id="O14920-4"/>
<property type="nucleotide sequence ID" value="NM_001242778.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001547.1">
<molecule id="O14920-1"/>
<property type="nucleotide sequence ID" value="NM_001556.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.597664"/>
<dbReference type="PDB" id="3BRT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/C=701-730"/>
</dbReference>
<dbReference type="PDB" id="3BRV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/C=701-745"/>
</dbReference>
<dbReference type="PDB" id="4E3C">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.98"/>
<property type="chains" value="A/B/C/D/E/F=11-669"/>
</dbReference>
<dbReference type="PDB" id="4KIK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.83"/>
<property type="chains" value="A/B=2-664"/>
</dbReference>
<dbReference type="PDBsum" id="3BRT"/>
<dbReference type="PDBsum" id="3BRV"/>
<dbReference type="PDBsum" id="4E3C"/>
<dbReference type="PDBsum" id="4KIK"/>
<dbReference type="ProteinModelPortal" id="O14920"/>
<dbReference type="SMR" id="O14920"/>
<dbReference type="BioGrid" id="109767">
<property type="interactions" value="141"/>
</dbReference>
<dbReference type="CORUM" id="O14920"/>
<dbReference type="DIP" id="DIP-27527N"/>
<dbReference type="ELM" id="O14920"/>
<dbReference type="IntAct" id="O14920">
<property type="interactions" value="76"/>
</dbReference>
<dbReference type="MINT" id="MINT-107608"/>
<dbReference type="STRING" id="9606.ENSP00000430684"/>
<dbReference type="BindingDB" id="O14920"/>
<dbReference type="ChEMBL" id="CHEMBL1991"/>
<dbReference type="DrugBank" id="DB06151">
<property type="generic name" value="Acetylcysteine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00945">
<property type="generic name" value="Acetylsalicylic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01169">
<property type="generic name" value="Arsenic trioxide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00995">
<property type="generic name" value="Auranofin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00244">
<property type="generic name" value="Mesalazine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05183">
<property type="generic name" value="MLN0415"/>
</dbReference>
<dbReference type="DrugBank" id="DB00795">
<property type="generic name" value="Sulfasalazine"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2039"/>
<dbReference type="iPTMnet" id="O14920"/>
<dbReference type="PhosphoSitePlus" id="O14920"/>
<dbReference type="BioMuta" id="IKBKB"/>
<dbReference type="EPD" id="O14920"/>
<dbReference type="MaxQB" id="O14920"/>
<dbReference type="PaxDb" id="O14920"/>
<dbReference type="PeptideAtlas" id="O14920"/>
<dbReference type="PRIDE" id="O14920"/>
<dbReference type="DNASU" id="3551"/>
<dbReference type="Ensembl" id="ENST00000416505">
<molecule id="O14920-4"/>
<property type="protein sequence ID" value="ENSP00000404920"/>
<property type="gene ID" value="ENSG00000104365"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000519735">
<molecule id="O14920-3"/>
<property type="protein sequence ID" value="ENSP00000430483"/>
<property type="gene ID" value="ENSG00000104365"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000520810">
<molecule id="O14920-1"/>
<property type="protein sequence ID" value="ENSP00000430684"/>
<property type="gene ID" value="ENSG00000104365"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000520835">
<molecule id="O14920-2"/>
<property type="protein sequence ID" value="ENSP00000430868"/>
<property type="gene ID" value="ENSG00000104365"/>
</dbReference>
<dbReference type="GeneID" id="3551"/>
<dbReference type="KEGG" id="hsa:3551"/>
<dbReference type="UCSC" id="uc003xow.3">
<molecule id="O14920-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3551"/>
<dbReference type="DisGeNET" id="3551"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000104365.13"/>
<dbReference type="GeneCards" id="IKBKB"/>
<dbReference type="HGNC" id="HGNC:5960">
<property type="gene designation" value="IKBKB"/>
</dbReference>
<dbReference type="HPA" id="CAB004447"/>
<dbReference type="HPA" id="HPA001249"/>
<dbReference type="MalaCards" id="IKBKB"/>
<dbReference type="MIM" id="603258">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615592">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O14920"/>
<dbReference type="OpenTargets" id="ENSG00000104365"/>
<dbReference type="Orphanet" id="397787">
<property type="disease" value="Severe combined immunodeficiency due to IKK2 deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA29776"/>
<dbReference type="eggNOG" id="KOG4250">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XRMU">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00900000140902"/>
<dbReference type="HOGENOM" id="HOG000038048"/>
<dbReference type="HOVERGEN" id="HBG018241"/>
<dbReference type="InParanoid" id="O14920"/>
<dbReference type="KO" id="K07209"/>
<dbReference type="OMA" id="WINEINI"/>
<dbReference type="OrthoDB" id="EOG091G02VC"/>
<dbReference type="PhylomeDB" id="O14920"/>
<dbReference type="TreeFam" id="TF324269"/>
<dbReference type="BRENDA" id="2.7.11.10">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1169091">
<property type="pathway name" value="Activation of NF-kappaB in B cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236974">
<property type="pathway name" value="ER-Phagosome pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168638">
<property type="pathway name" value="NOD1/2 Signaling Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168927">
<property type="pathway name" value="TICAM1, RIP1-mediated IKK complex recruitment"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1810476">
<property type="pathway name" value="RIP-mediated NFkB activation via ZBP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-209543">
<property type="pathway name" value="p75NTR recruits signalling complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-209560">
<property type="pathway name" value="NF-kB is activated and signals survival"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871837">
<property type="pathway name" value="FCERI mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445989">
<property type="pathway name" value="TAK1 activates NFkB by phosphorylation and activation of IKKs complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-446652">
<property type="pathway name" value="Interleukin-1 family signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357905">
<property type="pathway name" value="Regulation of TNFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357956">
<property type="pathway name" value="TNFR1-induced NFkappaB signaling pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602636">
<property type="pathway name" value="IKBKB deficiency causes SCID"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603027">
<property type="pathway name" value="IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603029">
<property type="pathway name" value="IkBA variant leads to EDA-ID"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607764">
<property type="pathway name" value="CLEC7A (Dectin-1) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5684264">
<property type="pathway name" value="MAP3K8 (TPL2)-dependent MAPK1/3 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933542">
<property type="pathway name" value="TRAF6 mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933543">
<property type="pathway name" value="NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937039">
<property type="pathway name" value="IRAK1 recruits IKK complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937041">
<property type="pathway name" value="IKK complex recruitment mediated by RIP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975144">
<property type="pathway name" value="IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation"/>
</dbReference>
<dbReference type="SABIO-RK" id="O14920"/>
<dbReference type="SignaLink" id="O14920"/>
<dbReference type="SIGNOR" id="O14920"/>
<dbReference type="ChiTaRS" id="IKBKB">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O14920"/>
<dbReference type="GeneWiki" id="IKK2"/>
<dbReference type="GenomeRNAi" id="3551"/>
<dbReference type="PRO" id="PR:O14920"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000104365"/>
<dbReference type="CleanEx" id="HS_IKBKB"/>
<dbReference type="ExpressionAtlas" id="O14920">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O14920">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0035631">
<property type="term" value="C:CD40 receptor complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009898">
<property type="term" value="C:cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0008385">
<property type="term" value="C:IkappaB kinase complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0008384">
<property type="term" value="F:IkappaB kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097110">
<property type="term" value="F:scaffold protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009653">
<property type="term" value="P:anatomical structure morphogenesis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002479">
<property type="term" value="P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030866">
<property type="term" value="P:cortical actin cytoskeleton organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002756">
<property type="term" value="P:MyD88-independent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1903347">
<property type="term" value="P:negative regulation of bicellular tight junction assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035509">
<property type="term" value="P:negative regulation of myosin-light-chain-phosphatase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070423">
<property type="term" value="P:nucleotide-binding oligomerization domain containing signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072659">
<property type="term" value="P:protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903140">
<property type="term" value="P:regulation of establishment of endothelial barrier"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042325">
<property type="term" value="P:regulation of phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010803">
<property type="term" value="P:regulation of tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051403">
<property type="term" value="P:stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033209">
<property type="term" value="P:tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR022007">
<property type="entry name" value="IKKbetaNEMObind"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR029071">
<property type="entry name" value="Ubiquitin-like_domsf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000626">
<property type="entry name" value="Ubiquitin_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF12179">
<property type="entry name" value="IKKbetaNEMObind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01239">
<property type="entry name" value="IKKbetaNEMObind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54236">
<property type="entry name" value="SSF54236"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0379">Hydroxylation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0702">S-nitrosylation</keyword>
<keyword id="KW-0705">SCID</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Inhibitor of nuclear factor kappa-B kinase subunit beta" id="PRO_0000086013">
<location>
<begin position="1"/>
<end position="756"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="9">
<location>
<begin position="15"/>
<end position="300"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="9">
<location>
<begin position="21"/>
<end position="29"/>
</location>
</feature>
<feature type="region of interest" description="Leucine-zipper">
<location>
<begin position="458"/>
<end position="479"/>
</location>
</feature>
<feature type="region of interest" description="NEMO-binding">
<location>
<begin position="737"/>
<end position="742"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="9 10">
<location>
<position position="145"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="9">
<location>
<position position="44"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1 and PKC/PRKCZ" evidence="11 12 14">
<location>
<position position="177"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine" evidence="23">
<location>
<position position="179"/>
</location>
</feature>
<feature type="modified residue" description="O-acetylthreonine; by Yersinia yopJ" evidence="33">
<location>
<position position="180"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1, PKC/PRKCZ and PDPK1" evidence="11 12 14 27">
<location>
<position position="181"/>
</location>
</feature>
<feature type="modified residue" description="Hydroxyproline" evidence="32">
<location>
<position position="191"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="58">
<location>
<position position="670"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 5 12">
<location>
<position position="672"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6">
<location>
<position position="675"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="5 6 58">
<location>
<position position="675"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="58">
<location>
<position position="682"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="58">
<location>
<position position="689"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="58">
<location>
<position position="692"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="58">
<location>
<position position="695"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="58">
<location>
<position position="697"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="58">
<location>
<position position="705"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="58">
<location>
<position position="733"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="58">
<location>
<position position="740"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="58">
<location>
<position position="750"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="28">
<location>
<position position="163"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_043408" evidence="55">
<original>MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMR</original>
<variation>MSSDGTI</variation>
<location>
<begin position="1"/>
<end position="66"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_041825" evidence="55">
<original>MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHN</original>
<variation>MFSGGCHSPGFGRPSPAFPAPGSPPPAPRPCR</variation>
<location>
<begin position="1"/>
<end position="34"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041826" evidence="56">
<original>WHSKVRQKSEVDIVVSEDLNGTVKFS</original>
<variation>CVRMWPGTVAHSCNPSTLGGRGRWIS</variation>
<location>
<begin position="231"/>
<end position="256"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041827" evidence="56">
<location>
<begin position="257"/>
<end position="756"/>
</location>
</feature>
<feature type="sequence variant" description="In breast cancer samples; infiltrating ductal carcinoma; somatic mutation." id="VAR_035626" evidence="31 36">
<original>A</original>
<variation>S</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56411242." id="VAR_040567" evidence="36">
<original>Q</original>
<variation>R</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2272736." id="VAR_040568" evidence="36">
<original>R</original>
<variation>Q</variation>
<location>
<position position="526"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17875749." id="VAR_021124" evidence="54">
<original>R</original>
<variation>W</variation>
<location>
<position position="554"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34309584." id="VAR_040569" evidence="36">
<original>A</original>
<variation>T</variation>
<location>
<position position="710"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56301637." id="VAR_040570" evidence="36">
<original>F</original>
<variation>L</variation>
<location>
<position position="734"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17611716." id="VAR_051628">
<original>A</original>
<variation>T</variation>
<location>
<position position="736"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity and no effect on binding to NIK." evidence="51 52">
<original>K</original>
<variation>A</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="mutagenesis site" description="Monoubiquitinated; when associated with E-177 and E-181." evidence="40">
<original>K</original>
<variation>R</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="mutagenesis site" description="COmplete loss of TBK1-mediated phosphorylation." evidence="14">
<original>SLCTS</original>
<variation>ALCTA</variation>
<location>
<begin position="177"/>
<end position="181"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of activity." evidence="40 51">
<original>S</original>
<variation>A</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="mutagenesis site" description="Full activation. Interaction with TRIM21 is enhanced; when associated with E-181. Monoubiquitinated; when associated with R-163 and E-181. Strongly promoted NF-kappa-B gene expression; when associated with E-181." evidence="40 51">
<original>S</original>
<variation>E</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of activity." evidence="40 51">
<original>S</original>
<variation>A</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="mutagenesis site" description="Full activation. Interaction with TRIM21 is enhanced; when associated with E-177. Monoubiquitinated; when associated with R-163 and E-177. Strongly promoted NF-kappa-B gene expression; when associated with E-177." evidence="40 51">
<original>S</original>
<variation>E</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of hypoxic inducibility." evidence="32">
<original>P</original>
<variation>A</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG63942/BAH14789." ref="5" evidence="57">
<original>L</original>
<variation>S</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="15"/>
<end position="22"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="29"/>
<end position="34"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="44"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="52"/>
<end position="67"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="81"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="84"/>
<end position="86"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="87"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="94"/>
<end position="97"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="104"/>
<end position="109"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="111"/>
<end position="113"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="119"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="151"/>
<end position="155"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="157"/>
<end position="164"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="182"/>
<end position="185"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="186"/>
<end position="188"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="191"/>
<end position="195"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="202"/>
<end position="217"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="228"/>
<end position="235"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="244"/>
<end position="247"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="253"/>
<end position="258"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="267"/>
<end position="280"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="285"/>
<end position="289"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="292"/>
<end position="294"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="296"/>
<end position="298"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="299"/>
<end position="307"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="310"/>
<end position="316"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="317"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="321"/>
<end position="327"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="333"/>
<end position="344"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="348"/>
<end position="350"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="353"/>
<end position="355"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="367"/>
<end position="370"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="382"/>
<end position="385"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="386"/>
<end position="389"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="408"/>
<end position="415"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="423"/>
<end position="499"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="500"/>
<end position="504"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="509"/>
<end position="520"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="527"/>
<end position="548"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="559"/>
<end position="575"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="579"/>
<end position="581"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="588"/>
<end position="661"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="706"/>
<end position="729"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="734"/>
<end position="736"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="740"/>
<end position="742"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BRV"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KIK"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O88351"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QY78"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10022904"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10195894"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10356400"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10783893"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10848580"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11297557"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11971985"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12133833"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12612076"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14739303"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15084260"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15173580"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15184672"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15456791"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15951441"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16177806"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16207722"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16267042"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16497931"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16728640"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17114296"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17116858"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17213322"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17287217"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17684021"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18626576"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18930133"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19675099"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19716809"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20410276"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20434986"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20797629"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21138416"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23091055"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23453969"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24369075"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26334375"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27426725"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9346484"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9346485"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9751059"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="55" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000305"/>
<evidence key="58" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10195894"/>
</source>
</evidence>
<sequence length="756" mass="86564" checksum="F9CADF671AE9E14E" modified="1998-01-01" version="1">
MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCL
EIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREG
AILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCT
SFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSE
VDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCF
KALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLA
LIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRN
LAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLK
AKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMAL
QTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQS
FEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKI
ACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLE
NAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>